KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) Other Non Operating Income (2016 - 2025)

Labcorp Holdings' Other Non Operating Income history spans 17 years, with the latest figure at -$19.4 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 218.29% year-over-year to -$19.4 million; the TTM value through Dec 2025 reached -$55.0 million, down 191.36%, while the annual FY2025 figure was -$55.0 million, 191.36% down from the prior year.
  • Other Non Operating Income for Q4 2025 was -$19.4 million at Labcorp Holdings, down from -$1.9 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $31.9 million in Q3 2021 and bottomed at -$36.0 million in Q4 2021.
  • The 5-year median for Other Non Operating Income is $1.6 million (2024), against an average of $200000.0.
  • The largest annual shift saw Other Non Operating Income plummeted 348.94% in 2022 before it soared 389.86% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at -$36.0 million in 2021, then soared by 185.0% to $30.6 million in 2022, then tumbled by 40.52% to $18.2 million in 2023, then dropped by 9.89% to $16.4 million in 2024, then plummeted by 218.29% to -$19.4 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Other Non Operating Income are -$19.4 million (Q4 2025), -$1.9 million (Q3 2025), and -$32.7 million (Q2 2025).